LAUSR

Graphical abstract Figure. No Caption available. Abstract Hydrogen sulfide (H2S) and carbon monoxide (CO) exert gastroprotection against acute gastric lesions. We determined the cross‐talk between H2S and CO in gastric ulcer healing process and regulation of gastric blood flow (GBF) at ulcer margin. Male Wistar rats with acetic acid‐induced gastric ulcers were treated i.g. throughout 9 days with vehicle (control), NaHS (0.1–10 mg/kg) +/− zinc protoporphyrin (ZnPP, 10 mg/kg), d,l‐propargylglycine (PAG, 30 mg/kg), CO‐releasing CORM‐2 (2.5 mg/kg) +/− PAG. GBF was assessed by laser flowmetry, ulcer area was determined by planimetry/histology. Gastric mucosal H2S production was analysed spectrophotometrically. Protein and/or mRNA expression at ulcer margin for vascular endothelial growth factor (VEGF)A, epidermal growth factor receptor (EGFr), cystathionine‐&ggr;‐lyase (CSE), cystathionine‐&bgr;‐synthase (CBS), 3‐mercaptopyruvate sulfurtransferase (3‐MST), heme oxygenases (HOs), nuclear factor (erythroid‐derived 2)‐like 2 (Nrf‐2), cyclooxygenase (COX)‐2, inducible nitric oxide synthase (iNOS), IL‐1&bgr;, TNF‐&agr; and hypoxia inducible factor (HIF)‐1&agr; were determined by real‐time PCR or western blot. IL‐1&agr;, IL‐1&bgr;, IL‐2, IL‐4, IL‐5, IL‐6, IL‐10, IL‐12, IL‐13, IFN‐&ggr;, TNF‐&agr;, GM‐CSF plasma concentration was assessed using Luminex platform. NaHS dose‐dependently decreased ulcer area and increased GBF but ZnPP attenuated these effects. PAG decreased H2S production but failed to affect CORM‐2‐mediated ulcer healing and vasodilation. NaHS increased Nrf‐2, EGFr, VEGFA and decreased pro‐inflammatory markers expression and IL‐1&bgr;, IL‐2, IL‐13, TNF‐&agr;, GM‐CSF plasma concentration. CORM‐2 decreased IL‐1&bgr; and GM‐CSF plasma levels. We conclude that NaHS accelerates gastric ulcer healing increasing microcirculation and Nrf‐2, EGFr, VEGFA expression. H2S‐mediated ulcer healing involves endogenous CO activity while CO does not require H2S. NaHS decreases systemic inflammation more effectively than CORM‐2.